Patient Recruitment · 2026

Patient Source Mix for Rare Disease vs Common Conditions

There's no single “correct” recruitment source strategy. The right mix depends almost entirely on one variable most planning conversations underweight: how many eligible patients exist, and how concentrated or dispersed they are.

Patient source mix for rare disease vs common conditions comes down to one variable most planning conversations underweight: how many eligible patients exist, and how concentrated or dispersed they are.

What is a rare or highly specialised patient population, recruitment-wise?

A rare or highly specialised condition has a small, often geographically dispersed patient population, frequently connected through specific clinical relationships and community structures rather than general awareness. This makes it a search problem: finding a small number of specific, often hard-to-identify patients, where relevance is scarce and worth prioritising over reach.

Clinicians and specialists who see this condition regularly often personally know a meaningful share of the eligible patient pool, which is why a narrow, carefully chosen set of channels usually outperforms a broad one for this kind of study — a dynamic covered in more depth in how referral networks actually work.

What is a common-condition patient population, recruitment-wise?

A common condition has a large, broadly distributed population, reachable through many channels, where the constraint is usually relevance and targeting rather than sheer availability of patients. This makes it a filtering problem: reaching enough of a large population while keeping the source mix relevant enough that referrals actually convert, which is a fundamentally different challenge from a search problem — one that benefits from the kind of scalable delivery a rare-disease study rarely needs.

How does the right source mix compare, channel by channel?

Personal referral networks matter disproportionately for a rare or highly specialised condition. In a small population, clinicians and specialists who see this condition regularly often personally know a meaningful share of the eligible pool, and a referral network built around these relationships can outperform a much larger, less targeted campaign. Patient advocacy and condition-specific communities carry real weight too, because rare-disease patients are frequently connected to each other precisely because their condition is uncommon enough that finding others with it matters to them.

For a common condition, the calculation shifts. Digital and search advertising perform well because there's enough search volume and audience scale to make targeting effective, generating a continuous stream of fresh enquiries rather than relying on a fixed, decaying list. GP and physician referral remains valuable but represents a smaller share of the total addressable population than it does for a rare condition, simply because there are many more potential entry points overall.

What does the evidence say about channel effectiveness in practice?

A 2023 study in the Journal of Medical Internet Research tracked recruitment channels for six rare-disease studies and found sharp differences in conversion, not just raw referral volume. A patient registry/email contact channel converted 18.22% of its referrals into consented leads, while organic Facebook converted 6.8% and paid Facebook advertising converted just 1% — despite paid advertising being run on a real, if modest, budget of $585 across a seven-month campaign. Advocacy-amplified organic channels, even where they produced fewer raw referrals than paid ads, were identified as among the most effective at generating genuine leads.

What's the trap in both directions?

The most common mistake with rare and specialist populations is chasing volume through broad channels when the actual constraint is finding a small, specific group of people — more channels doesn't create more eligible patients, it just spreads the same limited effort more thinly. The most common mistake with common conditions is the opposite: relying too heavily on a small number of channels, often out of habit or comfort with an established source, when the size of the population would support a broader, more diversified strategy that reaches more of the addressable pool. Both mistakes come from applying one population's logic to the other's problem, and both are one reason a study can look reasonable on paper — a topline number that, on its own, hides which specific mismatch is driving the gap, much like the hidden cost of a good enough recruitment percentage.

Where do existing patient databases fit differently?

An existing patient database behaves differently depending on population type. For a rare condition, a well-maintained database tied to a specific patient community can represent a genuinely significant and hard-to-replace source, because the population it is drawn from is itself scarce. For a common condition, the same kind of database is a much smaller fraction of the addressable population, and its value depends more heavily on how current the records are — contact and email lists degrade by roughly 23% a year on average, so a static list decays faster in relative usefulness when a much larger pool of not-yet-contacted eligible patients exists elsewhere. Whichever population you're recruiting, how fast a database referral actually reaches someone still depends on the same first-contact speed that determines whether any channel converts.

What should you check when building your source mix?

• How many eligible patients likely exist for this study, and how are they currently connected to each other and to clinical care?
• For a narrow, specific population — are you prioritising clinical relationships, advocacy and community channels, and existing site connections over broad reach?
• For a large, distributed population — is a wider, diversified mix in place, with digital and search channels doing genuine work rather than serving as a supplement?
• For each channel currently running, does it have a structural reason to reach this specific population, or is it there out of habit?

A structured recruitment diagnostic reads source mix against the study's own population difficulty, rather than scoring channel selection the same way regardless of what population is being recruited.

Frequently asked questions